MCL1 and malignant colon neoplasm: In summary, the results of in vitro and in vivo suggest the triple combination of 5-FU+DTN+DHA lead to a significant anticancer selectivity and overcome of drug resistance in colon cancer by the mechanism of ROS-mediated Mcl-1 ubiquitination and apoptosis, may be an effective strategy for novel colon cancer treatment.